Baird-backed Apervita appoints Bradley as board chair

Apervita, a healthcare-focused platform-as-a-service company, has named James P. Bradley as chair and independent director for its board of directors. Bradley is chief information officer of UnitedHealthCare and chief technology strategy officer at McKesson Corporation. Apervita is a portfolio company of Baird Capital.


CHICAGO, May 7, 2018 – Apervita, Inc. announced today the addition of James P. Bradley as Chair and Independent Director for Apervita’s Board of Directors.

Jim Bradley brings a wealth of experience to Apervita as a technologist, executive, entrepreneur, and Board leader. His successful career includes serving with some of the health industry’s most notable companies and organizations, partnering with the federal government on strategic national health programs, and building some of the most transformative and successful health startups. Mr. Bradley served as Chief Information Officer of UnitedHealthCare, Chief Technology Strategy Officer at McKesson Corporation, and Chair at the National Committee for Quality Assurance (NCQA).

Jim’s collaboration with the public sector includes his partnership with Northrop Grumman Corporation as the Program Director for their contract with U.S. Health and Human Services to develop a prototype infrastructure of a national health information network. Jim also chaired the Board of the national Health Data Consortium.

Jim founded and led companies such as and RxHub (now Surescripts) as well as serving as a Board member and Chair of companies such as ABILITY Network and Wellpartner, both of which accomplished very successful exits for their stakeholders. In addition to Apervita, Jim currently Chairs the Boards of two other healthcare companies, Apixio and NovuHealth. Jim frequently volunteers his time on behalf of not-for-profit organizations striving to advance the state of health information technology. One such example was his role as Chairman of the Board of Trustees of the University of Minnesota Medical Center/Fairview.

“I am excited to serve as Chairman of the Board of Apervita,” said Jim Bradley. “What Apervita has already accomplished is not previously seen in Healthcare. That is a true testament to the leadership team and its vision. By building a platform that empowers the industry to deliver value faster and reduce cost across many areas of care, they are providing a capability that is truly revolutionary for the industry. “

“Apervita serves some of the largest and fastest growing, as well as the most conservative, enterprises in healthcare. Jim is a luminary that has built industry-scale health information platforms and companies that serve every corner of the industry. We are delighted to work with Jim as we expand our network and accelerate Apervita’s growth,” said Paul Magelli, CEO & Founder of Apervita.

About Apervita
Apervita is an industry-scale Platform-as-a-Service (PaaS) that empowers health enterprises to build, deploy and exchange analytic & data applications easily and affordably in order to get paid, improve performance and provide better care. Unlike traditional software solutions that lock in customers or custom-built solutions that cannot scale, Apervita believes health enterprises demand the independence to deliver many more solutions and collaborate with any number of partners on a platform that they control and manage. Apervita empower networks of healthcare providers, and the businesses they interact with daily, to create repeatable and reusable analytics & data solutions of nearly any kind, accelerating results and productivity for everyone. Apervita is a portfolio company of Baird Capital and is also backed by Optum Ventures, Pritzker Venture Capital, GE Ventures, and MATH Ventures.